全文获取类型
收费全文 | 2112565篇 |
免费 | 171453篇 |
国内免费 | 7617篇 |
专业分类
耳鼻咽喉 | 27453篇 |
儿科学 | 70454篇 |
妇产科学 | 58646篇 |
基础医学 | 297928篇 |
口腔科学 | 58956篇 |
临床医学 | 192378篇 |
内科学 | 422727篇 |
皮肤病学 | 49422篇 |
神经病学 | 171823篇 |
特种医学 | 84680篇 |
外国民族医学 | 568篇 |
外科学 | 324262篇 |
综合类 | 50634篇 |
现状与发展 | 2篇 |
一般理论 | 761篇 |
预防医学 | 169096篇 |
眼科学 | 46843篇 |
药学 | 150430篇 |
7篇 | |
中国医学 | 3862篇 |
肿瘤学 | 110703篇 |
出版年
2018年 | 21698篇 |
2016年 | 19934篇 |
2015年 | 22287篇 |
2014年 | 31107篇 |
2013年 | 47139篇 |
2012年 | 59641篇 |
2011年 | 63704篇 |
2010年 | 39123篇 |
2009年 | 37566篇 |
2008年 | 59532篇 |
2007年 | 63449篇 |
2006年 | 64669篇 |
2005年 | 62491篇 |
2004年 | 60152篇 |
2003年 | 58252篇 |
2002年 | 55642篇 |
2001年 | 99682篇 |
2000年 | 102351篇 |
1999年 | 85720篇 |
1998年 | 25360篇 |
1997年 | 22752篇 |
1996年 | 23545篇 |
1995年 | 23401篇 |
1994年 | 21752篇 |
1993年 | 20330篇 |
1992年 | 70543篇 |
1991年 | 68836篇 |
1990年 | 66678篇 |
1989年 | 64036篇 |
1988年 | 58988篇 |
1987年 | 58415篇 |
1986年 | 54906篇 |
1985年 | 53097篇 |
1984年 | 40325篇 |
1983年 | 33940篇 |
1982年 | 21004篇 |
1981年 | 18943篇 |
1980年 | 17764篇 |
1979年 | 36747篇 |
1978年 | 26701篇 |
1977年 | 22421篇 |
1976年 | 20973篇 |
1975年 | 21845篇 |
1974年 | 25995篇 |
1973年 | 25031篇 |
1972年 | 23085篇 |
1971年 | 21358篇 |
1970年 | 19712篇 |
1969年 | 18483篇 |
1968年 | 17126篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
821.
Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers. 总被引:6,自引:5,他引:1 下载免费PDF全文
Prior immunologic experience with homologous and heterologous serotype Salmonella strains potentiated the subsequent antibody response when the same strains were used as vaccine carriers of foreign antigens. This potentiation was positively correlated with the appearance of antibody directed against the lipopolysaccharide of the carrier strain. Both serum and mucosal antibody responses against the foreign antigen increased over time. Antibody responses in sera of animals primed with either the homologous or heterologous serotype strain were not statistically significantly different, while animals primed with the homologous serotype strain developed significantly better mucosal antibody responses against the foreign antigen. 相似文献
822.
Though maternal treatment with thyrotropin-releasing hormone (TRH) for prevention of hyaline membrane disease has been utilized, precise mechanisms of TRH in accelerating fetal lung maturation remain unclear. We studied the effect of maternally administered TRH or DN1417 (an analog of TRH) on functional and morphologic fetal rabbit lung maturation and the duration of survival after premature delivery. Because DN1417 retains the neurotransmitter but not the neuroendocrine effects of TRH, this study enables us to determine which of these effects was responsible for enhancement of lung maturation. TRH or DN1417 (0.2 mg/kg/dose) or saline was injected intravenously into New Zealand White rabbit does 48, 36, 24, 12 and 2 h prior to sacrifice on day 27 of gestation. Functional pulmonary maturity was assessed by pressure-volume hysteresis, and morphologic maturity was assessed by histologic technique. Maternal administration of TRH or DN1417 enhanced both functional and morphologic fetal lung maturation as well as the duration of neonatal survival after premature delivery. We propose that the effect of TRH in fetal lung maturation is due to neurotransmitter rather than neuroendocrine effects. 相似文献
823.
Facial reanimation after acoustic neuroma excision is currently accomplished using a variety of surgical techniques. A multi-institutional survey of patient perceptions of facial reanimation success was accomplished by mailing a questionnaire to 809 randomly selected members of the Acoustic Neuroma Association. Four hundred sixty patients who underwent 296 reanimation procedures responded. Facial to hypoglossal nerve anastomosis, tarsorrhaphy, and upper eyelid implants were most frequently performed. The patient's estimations of initial deficit, spontaneous recovery, and overall satisfaction with the reanimation procedures are discussed. 相似文献
824.
A prospective study of 17 cases of microsurgical reversal of tubal sterilization by a combined approach of laparoscopy and minilaparotomy was performed. Inclusion criteria included age less than 43; weight less than ideal body weight plus 20%; documentation of ovulation; 2 cm of proximal oviduct on hysterosalpingography; and a normal semen analysis or postcoital test. A comparison group of the 5 cases of sterilization reversal performed by a standard inpatient technique during the same period was analyzed. The study technique was performed on an outpatient basis in 15 of the 17 cases, 12 patients (71%) conceived 13 intrauterine pregnancies, one ectopic pregnancy occurred, and total patient costs and time until return to work were significantly less with the study versus standard technique. 相似文献
825.
Hitoshi Tajiri M.D Kosuke Kozaiwa M.D Tokuzo Harada M.D Yoshikazu Ozaki M.D Kazunori Miki M.D Kazuo Shimizu M.D Shintaro Okada M.D. 《Pediatrics international》1991,33(3):323-326
We assessed the efficacy of a government-sponsored mass protection program in Osaka, Japan, for perinatal HBV infection in infants born to HBeAg positive HBV carrier mothers. We also evaluated the impact of optional follow-up procedures in such infants, including an evaluation of anti-HBs response and a booster dose of HBV vaccine for poor responders. The results demonstrated that this mass protection program protected 94.4% of the infants from perinatal HBV infection in the Osaka area. However, the proportion of infants with an unprotective level of anti-HBs was higher in the standard group than in the follow-up group both at 1.0 and 1.5 years of age, which was also the case for HBV events. Furthermore, the present study showed that a booster dose of vaccine in poor responders was very effective in promoting an anti-HBs response. In conclusion, we recommend that a follow-up blood test to confirm a response of anti-HBs to HBV vaccine should be performed at 4–8 weeks after the third injection of HBV vaccine in infants born to HBeAg positive HBV carrier mothers. We also recommend that a booster injection of HBV vaccine should be immediately given to poor responding infants who otherwise are at a considerable risk of developing HBV infection in late infancy. 相似文献
826.
827.
828.
T. A. Creagh P. A. McLean M. G. Donovan J. J. Walshe D. M. Murphy 《Transplant international》1993,6(1):39-41
Reluctance to use kidneys from older donors (>50 years of age) is based on reports of inferior results. We reviewed our experience with 45 kidneys transplanted from older donors. Primary nonfunction, immediate graft function, and 1-, 2- and 3-year graft survival rates were similar to those obtained with kidneys transplanted from donors aged between 20 and 40 years. Renal function at 1 year (as measured by serum creatinine) was poorer in kidneys from older donors. No beneficial effect with respect to graft survival was noted with cyclosporin therapy compared to conventional immunosuppression; however, the numbers are small. We conclude that kidneys from older donors are a valuable source for transplantation. 相似文献
829.
PHILLIPS D.I.W.; COOPER C.; FALL C.; PRENTICE L.; OSMOND C.; BARKER D.J.P.; SMITH B. REES 《QJM : monthly journal of the Association of Physicians》1993,86(4):247-253
To determine whether fetal and infant growth could influencesusceptibility to autoimmune disease in adults, the occurrenceof thyroid autoantibodies and autoimmune thyroiditis was studiedin 305 women, aged 6071, born in Hertfordshire and forwhom details of birth weight, infant growth, and feeding wereroutinely recorded. Thyroglobulin autoantibody was detectedin 37% of the women, thyroid peroxidase autoantibody in 41%,and autoimmune thyroiditis, defined as biochemical or clinicalhypothyroidism in association with thyroid autoantibodies, in5.6%. The proportion of women with thyroglobulin and thyroidperoxidase auto antibodies fell with increasing birth weightbut was not related to weight at 1 year of age or the methodof infant feeding. The prevalence of both autoantibodies rosewith increasing adult body mass index but fell as the waistto hip ratio increased. These results demonstrate the importance of early environmentin determining the susceptibility to autoimmune thyroid disease.The contrasting effects of adult body mass index and waist tohip ratio on antibody prevalence could be explained by theirassociations with different hormonal environments. 相似文献
830.
D.-Y. LIN I.-S. SHEEN C.-M. CHU & Y.-F. LIAW 《Alimentary pharmacology & therapeutics》1996,10(6):961-966
Background : The clinical course of chronic hepatitis B is variable. Patients with hepatic decompensation, bridging necrosis or an alpha-fetoprotein level greater than 100 ng/mL during an exacerbation of hepatitis have a high risk of developing cirrhosis. This study was conducted to evaluate the effect of colchicine in the prevention of cirrhosis in such patients.
Methods : Patients with risk factor(s) were randomized to receive either colchicine 5 mg/week or no specific treatment, the end point being development of cirrhosis.
Results : After a follow up period of 4 years, the treatment group had a marked reduction in exacerbations of acute hepatitis (32% vs. 63%/patient/year, P <0.005). Seven out of 38 patients in the treatment group and 10 out of 27 patients in the control group developed cirrhosis. The calculated cumulative incidence of cirrhosis by the end of first, second, third and fourth years in the treatment group was 8.7, 18.6, 32 and 32%, respectively. The corresponding figures in the control group were 30, 35.5, 46.3 and 73.2%, respectively, with a P -value of 0.057.
Conclusions : The results suggest that colchicine may prevent cirrhosis in chronic hepatitis B patients with risk factor(s), possibly by suppressing exacerbations of hepatitis through an anti-inflammatory effect. 相似文献
Methods : Patients with risk factor(s) were randomized to receive either colchicine 5 mg/week or no specific treatment, the end point being development of cirrhosis.
Results : After a follow up period of 4 years, the treatment group had a marked reduction in exacerbations of acute hepatitis (32% vs. 63%/patient/year, P <0.005). Seven out of 38 patients in the treatment group and 10 out of 27 patients in the control group developed cirrhosis. The calculated cumulative incidence of cirrhosis by the end of first, second, third and fourth years in the treatment group was 8.7, 18.6, 32 and 32%, respectively. The corresponding figures in the control group were 30, 35.5, 46.3 and 73.2%, respectively, with a P -value of 0.057.
Conclusions : The results suggest that colchicine may prevent cirrhosis in chronic hepatitis B patients with risk factor(s), possibly by suppressing exacerbations of hepatitis through an anti-inflammatory effect. 相似文献